| 1 |
Phenothiazinium derivatives for pathogen inactivation in blood products
MARK S. WAINWRIGHT, H. Mohr, Wolfram H. Walker · Journal of Photochemistry and Photobiology B Biology
|
19 Sep 2006 |
128 |
| 2 |
Inactivation of Ebola virus and Middle East respiratory syndrome coronavirus in platelet concentrates and plasma by ultraviolet C light and methylene blue plus visible light, respectively
Markus Eickmann, Ute Gravemann, Wiebke Handke et al. · Transfusion
Open access |
6 May 2018 |
123 |
| 3 |
Main Properties of the THERAFLEX MB-Plasma System for Pathogen Reduction
Jerard Seghatchian, Wilhelm G. Struff, Stefan Reichenberg · Transfusion Medicine and Hemotherapy
Open access |
2011 |
81 |
| 4 |
Humoral Immune Response Against Human Bocavirus VP2 Virus-Like Particles
Juha Lindner, Lüdya Karalar, Sandra Zehentmeier et al. · Viral Immunology
|
Dec 2008 |
76 |
| 5 |
Non‐phthalate plasticizer DEHT preserves adequate blood component quality during storage in PVC blood bags
Linda Larsson, Per Sandgren, Sara Ohlsson et al. · Vox Sanguinis
Open access |
12 Sep 2020 |
48 |
| 6 |
Pathogen inactivation of platelets using ultraviolet C light: effect on in vitro function and recovery and survival of platelets
Saber Bashir, Philip Cookson, Michael D. Wiltshire et al. · Transfusion
|
21 Aug 2012 |
47 |
| 7 |
Inactivation of dengue, chikungunya, and Ross River viruses in platelet concentrates after treatment with ultraviolet C light
Helen M. Faddy, Jesse J. Fryk, Natalie A. Prow et al. · Transfusion
|
Mar 2016 |
44 |
| 8 |
Updates on pathogen inactivation of plasma using Theraflex methylene blue system
Jerard Seghatchian, Wolfram H. Walker, Stefan Reichenberg · Transfusion and Apheresis Science
|
20 May 2008 |
44 |
| 9 |
In vitro effects on platelets irradiated with short‐wave ultraviolet light without any additional photoactive reagent using the THERAFLEX UV‐Platelets method
Per Sandgren, Frank Tolksdorf, W. G. Struff et al. · Vox Sanguinis
|
22 Dec 2010 |
42 |
| 10 |
Reduction of Zika virus infectivity in platelet concentrates after treatment with ultraviolet C light and in plasma after treatment with methylene blue and visible light
Jesse J. Fryk, Denese C. Marks, Jody Hobson‐Peters et al. · Transfusion
|
17 Jul 2017 |
38 |
| 11 |
Dengue and chikungunya viruses in plasma are effectively inactivated after treatment with methylene blue and visible light
Jesse J. Fryk, Denese C. Marks, Jody Hobson‐Peters et al. · Transfusion
|
25 Jul 2016 |
30 |
| 12 |
In vitro Quality of Platelets with Low Plasma Carryover Treated with Ultraviolet C Light for Pathogen Inactivation
Lacey Johnson, Ryan A. Hyland, Shereen Siew Ling Tan et al. · Transfusion Medicine and Hemotherapy
Open access |
5 Nov 2015 |
27 |
| 13 |
Migration of di(2‐ethylhexyl) phthalate, diisononylcyclohexane‐1,2‐dicarboxylate and di(2‐ethylhexyl) terephthalate from transfusion medical devices in labile blood products: A comparative study
Aurélie Thelliez, Chryslain C. Sumian, Emmanuel Chazard et al. · Vox Sanguinis
Open access |
28 May 2023 |
18 |
| 14 |
Buffy coat platelets coming to America : Are we ready?
Richard R. Gammon, Dana V. Devine, Louis M. Katz et al. · Transfusion
|
10 Nov 2020 |
17 |
| 15 |
Inactivation of yellow fever virus in plasma after treatment with methylene blue and visible light and in platelet concentrates following treatment with ultraviolet C light
Helen M. Faddy, Jesse J. Fryk, Roy A. Hall et al. · Transfusion
|
3 May 2019 |
17 |
| 16 |
Analysis of leukocyte binding to depletion filters: role of passive binding, interaction with platelets, and plasma components
Reinhard Henschler, Brigitte Rüster, A. Steimle et al. · Annals of Hematology
|
9 Feb 2005 |
14 |
| 17 |
Cold stored platelets – Increasing understanding and acceptance
Richard R. Gammon, Jeffrey C. Hebert, Kyungyoon Min et al. · Transfusion and Apheresis Science
|
5 Jan 2023 |
12 |
| 18 |
Quality of methylene blue–treated fresh‐frozen plasma stored up to 27 months
Rainer Moog, Stefan Reichenberg, Albrecht Hoburg et al. · Transfusion
|
Feb 2010 |
9 |
| 19 |
Inactivation of Japanese encephalitis virus in plasma by methylene blue combined with visible light and in platelet concentrates by ultraviolet C light
Lina Rustanti, Jody Hobson‐Peters, Agathe M. G. Colmant et al. · Transfusion
|
23 Aug 2020 |
7 |
| 20 |
Factor VIII and fibrinogen recovery in plasma after Theraflex methylene blue-treatment: effect of plasma source and treatment time.
André Rapaille, Stefan Reichenberg, Tomé Najdovski et al. · PubMed
Open access |
Apr 2014 |
5 |
| 21 |
In vitro evaluation of platelet concentrates suspended in additive solution and treated for pathogen reduction: effects of clumping formation.
Azucena Castrillo, Ignacio Álvarez, Frank Tolksdorf · PubMed
Open access |
Apr 2015 |
4 |
| 22 |
Inactivation of SARS‐CoV ‐2 infectivity in platelet concentrates or plasma following treatment with ultraviolet C light or with methylene blue combined with visible light
Jody Hobson‐Peters, Alberto Anastacio Amarilla, Lina Rustanti et al. · Transfusion
Open access |
27 Dec 2022 |
3 |
| 23 |
Suppression of MLL-AF4 by Small Interfering RNAs Inhibits Proliferation and Induces Apoptosis in T(4;11)-Positive SEM Cells.
Johann Greil, Maria Thomas, Christian Huenefeld et al. · Blood
|
16 Nov 2004 |
0 |